Paolo Nucíforo
Researcher Next ID · RN-035247
Researcher · Biochemistry, Genetics and Molecular Biology
Vall d'Hebron Institut de Recerca
Barcelona, Spain
- Works count
- 883
- Citation count
- 20,292
- H-index
- 73
- i10-index
- 166
Research interests
Publications
The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology
Nature Cancer · 2022 · https://doi.org/10.1038/s43018-022-00332-x
A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors
Radiology · 2021 · https://doi.org/10.1148/radiol.2021200928
LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy
Nature Communications · 2019 · https://doi.org/10.1038/s41467-019-10369-9
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade
JNCI Journal of the National Cancer Institute · 2019 · https://doi.org/10.1093/jnci/djz042
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy099
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors
Advances in Anatomic Pathology · 2017 · https://doi.org/10.1097/pap.0000000000000161
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research
Advances in Anatomic Pathology · 2017 · https://doi.org/10.1097/pap.0000000000000162
Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer
Science · 2017 · https://doi.org/10.1126/science.aal5240
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourina
Advances in Anatomic Pathology · 2017 · https://doi.org/10.1097/pap.0000000000000161
Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer
Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx112
mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer
Nature · 2017 · https://doi.org/10.1038/nature22964
Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma
Cancer Research · 2017 · https://doi.org/10.1158/0008-5472.can-16-3556
Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab
JAMA Oncology · 2015 · https://doi.org/10.1001/jamaoncol.2015.0830
PIK3CA Mutations Are Associated With Decreased Benefit to Neoadjuvant Human Epidermal Growth Factor Receptor 2–Targeted Therapies in Breast Cancer
Journal of Clinical Oncology · 2015 · https://doi.org/10.1200/jco.2014.55.2158
Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration
Annals of Oncology · 2015 · https://doi.org/10.1093/annonc/mdv161
Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors
Annals of Oncology · 2013 · https://doi.org/10.1093/annonc/mdt419
NUMB controls p53 tumour suppressor activity
Nature · 2008 · https://doi.org/10.1038/nature06412
Mitf regulation of Dia1 controls melanoma proliferation and invasiveness
Genes & Development · 2006 · https://doi.org/10.1101/gad.406406
Frequent Alterations in the Expression of Serine/Threonine Kinases in Human Cancers
Cancer Research · 2006 · https://doi.org/10.1158/0008-5472.can-05-3489
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Nature · 2006 · https://doi.org/10.1038/nature05327
Current projects
No projects listed.